ASX - Delayed Quote AUD

CD Private Equity Fund III (CD3.AX)

1.1700
0.0000
(0.00%)
At close: May 20 at 3:33:40 PM GMT+10
Loading Chart for CD3.AX
  • Previous Close 1.1700
  • Open 1.1800
  • Bid 1.1750 x --
  • Ask 1.1900 x --
  • Day's Range 1.1450 - 1.1800
  • 52 Week Range 1.1000 - 1.4850
  • Volume 14,984
  • Avg. Volume 19,482
  • Market Cap (intraday) 84.273M
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jan 29, 2025
  • 1y Target Est --

CD Private Equity Fund III specializes in investments in small and specialised private equity funds targeting lower middle-market operating businesses in the United States.

www.cdfunds.com.au/fund3/

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: CD3.AX

View More

Performance Overview: CD3.AX

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

CD3.AX
1.56%
S&P/ASX 200 [XJO] (^AXJO)
2.32%

1-Year Return

CD3.AX
7.71%
S&P/ASX 200 [XJO] (^AXJO)
6.38%

3-Year Return

CD3.AX
60.14%
S&P/ASX 200 [XJO] (^AXJO)
16.84%

5-Year Return

CD3.AX
339.42%
S&P/ASX 200 [XJO] (^AXJO)
51.88%

Compare To: CD3.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CD3.AX

View More

Valuation Measures

Annual
As of 5/22/2025
  • Market Cap

    84.27M

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.68

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1.70%

  • Return on Equity (ttm)

    -2.83%

  • Revenue (ttm)

    -2.84M

  • Net Income Avi to Common (ttm)

    -3.83M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.1M

Research Analysis: CD3.AX

View More

Company Insights: CD3.AX

Research Reports: CD3.AX

View More

People Also Watch